Pre-Market | Seeking Options

3. Paper: A Phase 1 Study of TTI-621, a Novel Immune Checkpoint Inhibitor Targeting CD47, in Patients with Relapsed or Refractory Hematologic Malignancies

Stephen Ansell, MD, PhD 1 , Robert W Chen, MD 2 , Ian W. Flinn, MD, PhD 3 , Michael B. Maris, MD 4 , Owen A. O’Connor, MD, PhD 5 , Lisa DS Johnson, PhD 6 * , Meghan Irwin 6 * , Penka S. Petrova, PhD 6 * , Robert A. Uger, PhD 7 * and Eric L Sievers, MD 6

4. Hillary Clinton Still Leads a Tighter Race, Times/CBS News Poll Shows

Most voters say that their minds are made up and that late revelations about Mrs. Clinton and Donald J. Trump made no significant difference to them.

5. Wells Fargo Confirms SEC Probe Into Its Sales Practices

Wells Fargo confirmed that the Securities and Exchange Commission is one of the agencies probing matters related to its sales practices.

6. Inside Wells Fargo, workers say the mood is grim

Wells Fargo workers tell CNNMoney they are angry at the bank for shifting blame on them and remain scared of being retaliated against for speaking up about bad behavior.

7. New Goldman ETF tracks popular hedge fund stock bets

Goldman Sachs Group Inc has launched a new exchange traded fund that mimics the most popular stock bets made by hedge funds, the bank said on Thursday.

8. Trillium Therapeutics Announces Investor and Scientific Presentation Schedule for Remainder of 2016

TORONTO, Nov. 3, 2016 — Trillium Therapeutics Inc. (NASDAQ: TRIL; TSX: TR) , a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, is scheduled to present an update on the company’s programs and progress at several upcoming conferences in 2016. Investor Conference: Oppenheimer Life Sciences Summit Attendee: Niclas Stiernholm, PhD, Trillium Chief Executive Officer Date and Time: Nov. 29, 2016 Location: Sofitel Hotel, New York City Scientific Conferences: The Society for Immunotherapy of Cancer (SITC) 31st Annual Meeting Presenter: Lisa Johnson, PhD, Trillium Research Scientist Title: CD47 is Overexpressed on Merkel Cell Carcinoma and a Target for SIRPαFc Therapy Date and Time: Nov. 11, 2016, 12:15 – 1:30 p.m. and 6:15 – 7:30 p.m. ET Location: Gaylord National Hotel Convention Center, National Harbor, MD American Society of Hematology (ASH) 58th Annual Meeting Presenter: Stephen Ansell, MD, Division of Hematology,

Technology News

1. Office 365 is the universal toolkit & today we added a new tool….chat-based workspace #MicrosoftTeams

2. ICYMI – watch the #MicrosoftTeams announcement on demand:

3. Facebook quarterly revenue now at $7B, +59% annually. Staggering (if not unprecedented) growth at this kind of scale

4. NOOOO, the little flip-out arms to wrap the cable on the power brick are gone! WHY?! the future is a tangled mess

5. Slack responds to Microsoft’s impending imitation with what I think is a Californian attempt at New York sarcasm

6. this makes me want to blindly immediately use whatever the microsoft thing is

7. The irony is this “open platform” bans third-party clients (

8. We’ve partnered with @Uber to bring the Foursquare tips you love to the new Uber app.

9. edit suggestion to @SlackHQ. Just write a two word post: “Remember Yammer?”

10. NEW 13min @MSFTMechanics’ depth video on “Microsoft Teams – using, enabling and managing”:

PRE-MARKET | November 02, 2016 | $BABA, $TWX, $FB, $FIT, $XOM, $QCOM, $YELP, $SPX, $TLT, $ES_F, #earnings #FOMC #Traders

by Alpha | Nov 2, 2016 | Pre-Market

PRE-MARKET MOVERS

1. PTN:

$PTN Palatin Female Libido-Boosting Shot Fails Crucial Sex Frequency Test – Adam F

2. PTN:

$PTN Palatin female sexual desire drug succeeds in trials; shares soar – Reuters

3. AVXS:

$AVXS AveXis Announces Single-Arm Design for US Pivotal Study of AVXS-101 in SMA Type 1 Patients – GN

4. OCLR:

$OCLR Oclaro tops Street 1Q forecasts – AP

5. YELP:

$YELP Yelp shares jump after company reports surprise profit – MarketWatch

6. AVGO, BRCD:

$BRCD Chipmaker Broadcom $AVGO to buy network gear maker Brocade for $5.5 billion – Reuters

7. EA:

$EA Electronic Arts Says Revenue Up, Raises Outlook – WSJ

8. SQ:

$SQ Dorsey’s Square posts jump in revenue, raises full-year forecast – Reuters’

9. CXRX:

$CXRX Concordia Int’l Appoints Allan Oberman as New CEO, Jordan Kupinsky as Chairman – SI

10. BABA:

$BABA Alibaba Jumps On Q3 Earnings Beat; Cloud Loss Narrowed – Barron’s

11. TWX:

$TWX Time Warner Beats Estimates on Cable Fees, ‘Suicide Squad’ – BBG

12. CYH:

$CYH Community Health Systems Swings to Loss – WSJ

13. ZTS:

$ZTS Zoetis Tops Q3 EPS by 1c; Updates FY16, FY17 Guidance – Street Insider

14. ETSY:

$ETSY Etsy shares see-saw after company’s Q3 results – MW

15. ADP, WAGE:

$ADP WageWorks $WAGE to buy two of Automatic Data Processing Inc’s businesses – Reuters

16. VSI: $VSI Vitamin Shoppe Misses Q3 EPS by 1c; Updates FY16 EPS Outlook – Street Insider

17. AGN: $AGN Allergan Misses Q3 Earnings & Sales; Ups Buyback Plan – Zacks

18. Z, ZG: $ZG Zillow $Z reports revenue jump, lifts outlook – MarketWatch

19. TRNC: $TRNC Tronc Loss Widens as Advertising Revenue Falls 11% – WSJ

20. TEL: $TEL TE Connectivity Tops Q4 EPS by 7c; Issues Solid Outlook – Street Insider

21. AVH, DAL, UAL: $AVH Delta $DAL, United $UAL Said to Near Avianca Bids Amid Elliott Talks – BBG

22. TRIL: $TRIL Trillium therapeutics says advances TTI-621 into early stage cohort expansion enrollment

23. GILD:

$GILD Gilead Quarterly Profit Misses on Low Hepatitis C Drug Sales – BBG

24. SCTY, TSLA:

$TSLA Tesla says SolarCity $SCTY would add $1 billion to 2017 revenue – Reuters

25. CLX:

$CLX Clorox earnings fall short, lowers outlook – MarketWatch

26. HLF:

$HLF Herbalife names new CEO, stock falls despite earnings beat – MarketWatch

27. ILMN:

$ILMN Illumina slashes annual earnings outlook – MarketWatch

28. VRX:

$VRX Valeant Pharma Affirms Being in Discussions for Various Divestitures; May Include Salix Sale – SI

29. MYGN:

$MYGN Myriad Genetics Misses Q1 EPS by 2c; Maintains Outlook – Street Insider

30. CERN:

$CERN Cerner Shares Drop on Disappointing Results, Cautious Outlook – WSJ

31. X:

$X U.S. Steel Cuts Annual View, Posts Third-Quarter Profit – WSJ

32. PAYC:

$PAYC Paycom Software Earnings Top But Shares Fall Late – IBD

33. DATA:

$DATA Tableau stock tumbles on mixed earnings results in latest blow to data visualization company

34. DHT:

$DHT DHT Holdings reports 3Q loss – AP

35. DXCM:

$DXCM DexCom, Inc. Reports Third Quarter 2016 Financial Results – Business Wire

36. ZAGG:

$ZAGG ZAGG Inc Stock / Shares Take a Tumble on Reported Third Quarter Loss – Warrior Trading

37. CEMP:

$CEMP Cempra on Watch as FDA Briefing Docs Published – Street Insider

38. ADPT:

$ADPT Adeptus Health Inc. Is Sinking After Q3 Profit Disappoints – RTT

UPGRADES

1. AYR:FBR Capital Upgrades Aircastle Limited $AYR to Outperform

2. GILD:$GILD upgraded to Outperform at BMO Capital

3. MDCA:Telsey Upgrades MDC Partners $MDCA to Outperform

4. NSC:Norfolk Southern on watch after Argus upgrade

5. SQ:Credit Suisse Upgrades Square $SQ to Outperform; Better Growth, Leverage

DOWNGRADES

1. ADPT:Jefferies Downgrades Adeptus Health $ADPT to Hold, Slashes PT to $13

2. BKD:RBC Capital Downgrades Brookdale Senior Living $BKD to Outperform

3. CPN:UPDATE: UBS Downgrades Calpine Corporation $CPN to Neutral

4. DATA:William Blair Downgrades Tableau Software $DATA to Market Perform

5. FTR:Deutsche Bank Downgrades Frontier Communications $FTR to Hold

6. ILMN:$ILMN downgraded to Underweight at First Analysis

7. PAYC:JPMorgan Downgrades Paycom Software $PAYC to Neutral

8. PFE:$PFE downgraded to Hold at Argus, downgraded to Market Perform at BMO Capital

9. PLT:JPMorgan Downgrades Plantronics $PLT to Neutral

10. UIHC:JMP Securities Downgrades United Insurance Holdings $UIHC to Market Perform

11. WBMD:WebMD downgraded to neutral from buy at Mizuho. Price target cut to $52 from $63. $WBMD 11/1 close: 49.92 #stocks

12. XENT:JPMorgan Downgrades Intersect ENT $XENT to Neutral

EARNINGS

1. TEL:$TEL reports FQ4 earnings of $1.27 EPS and $3.33B Revs –

2. VSI:$VSI reports FQ3 earnings of 50c EPS and $314.89M Revs –

3. VSI:$VSI reports inline with the Estimize EPS Consensus and misses the Estimize Revenue Consensus by $2.04M –

4. BG:$BG reports FQ3 earnings of 73c EPS and $11.42B Revs –

5. FLOW:$FLOW reports FQ3 earnings of 34c EPS and $466.80M Revs –

6. FLOW:$FLOW reports inline with the Estimize EPS Consensus and misses the Estimize Revenue Consensus by $2.82M –

7. CLX:$CLX reports FQ1 earnings of $1.32 EPS and $1.44B Revs –

8. AGN:$AGN reports FQ3 earnings of $3.32 EPS and $3.62B Revs –

9. BAH:$BAH reports FQ2 earnings of 46c EPS and $1.40B Revs –

10. STE:$STE reports FQ2 earnings of 89c EPS and $646.42M Revs –

11. EL:$EL reports FQ1 earnings of 84c EPS and $2.87B Revs –

12. FUN:$FUN reports FQ3 earnings of $3.10 EPS and $650.28M Revs –

13. ABC:$ABC reports FQ4 earnings of $1.30 EPS and $37.56B Revs –

14. TWX:$TWX reports FQ3 earnings of $1.83 EPS and $7.17B Revs –

15. BABA:$BABA reports FQ2 earnings of 79c EPS and $5.14B Revs –

16. ADP:$ADP reports FQ1 earnings of 86c EPS and $2.92B Revs –

17. VMC:$VMC reports FQ3 earnings of $1.01 EPS and $1.01B Revs –

18. SHOP:$SHOP reports FQ3 earnings of -2c EPS and $99.58M Revs –

19. CEVA:$CEVA reports FQ3 earnings of 24c EPS and $17.85M Revs –

20. HSIC:$HSIC reports FQ3 earnings of $1.68 EPS and $2.87B Revs –

21. IPI:$IPI reports FQ3 earnings of -23c EPS and $43.64M Revs –

22. Q:$Q reports FQ3 earnings of $1 EPS and $1.14B Revs –

23. KATE:$KATE reports FQ3 earnings of 13c EPS and $277.33M Revs –

24. ALKS:$ALKS reports FQ3 earnings of -9c EPS and $180.24M Revs –

25. CRL:$CRL reports FQ3 earnings of $1.18 EPS and $425.72M Revs –

26. YELP:$YELP reports FQ3 earnings of 2c EPS and $186.23M Revs –

27. BDC:$BDC reports FQ3 earnings of $1.29 EPS and $602.47M Revs –

28. HZN:$HZN reports FQ3 earnings of 30c EPS and $151.72M Revs –

29. CLH:$CLH reports FQ3 earnings of 16c EPS and $729.52M Revs –

30. SABR:$SABR reports FQ3 earnings of 27c EPS and $838.98M Revs –

31. PCRX:$PCRX reports FQ3 earnings of 20c EPS and $68.36M Revs –

32. TRGP:$TRGP reports FQ3 earnings of -4c EPS and $1.65B Revs –

33. ZTS:$ZTS reports FQ3 earnings of 52c EPS and $1.24B Revs –

34. ORBC:$ORBC reports FQ3 earnings of -5c EPS and $46.29M Revs –

35. JLL:$JLL reports FQ3 earnings of $1.42 EPS and $1.71B Revs –

36. ORBK:$ORBK reports FQ3 earnings of 68c EPS and $204.95M Revs –

37. ODP:$ODP reports FQ3 earnings of 16c EPS and $2.84B Revs –

38. SEP:$SEP reports FQ3 earnings of 76c EPS and $628M Revs –

39. CDW:$CDW reports FQ3 earnings of 97c EPS and $3.71B Revs –

40. SE:$SE reports FQ3 earnings of 31c EPS and $1.08B Revs –

41. CRTO:$CRTO reports FQ3 earnings of 48c EPS and $176.56M Revs –

42. SNAK:$SNAK reports FQ3 earnings of -13c EPS and $66.53M Revs –

43. OZM:$OZM reports FQ3 earnings of 8c EPS and $148.10M Revs –

44. THR:$THR reports FQ2 earnings of 10c EPS and $68.81M Revs –

45. SBGI:$SBGI reports FQ3 earnings of 79c EPS and $693.80M Revs –

46. NYT:$NYT reports FQ3 earnings of 6c EPS and $363.55M Revs –

47. MNTA:$MNTA reports FQ3 earnings of -26c EPS and $29.14M Revs –

48. INGR:$INGR reports FQ3 earnings of $1.96 EPS and $1.49B Revs –

49. FLWS:$FLWS reports FQ1 earnings of -24c EPS and $165.83M Revs –

50. MMP:$MMP reports FQ3 earnings of 91c EPS and $551.78M Revs –

Trending Social Alerts

1. ANTM:$ANTM CEO Swedish on #Obamacare reforms: extend Cadillac Tax freeze, extend risk adjustment, flexibility on products, tighten grace period.

2. CEMP:Looks like Peter Griffin is back at posting adcomm briefing docs today. $CEMP #solithromycin

3. AGN:$AGN Announces $10 Billion Accelerated Share Repurchase, Initiation of Cash Dividend in 2017

4. BRCD:Broadcom to acquire Brocade Communications in $5.9B deal • $BRCD $AVGO

5. EA:Electronic Arts [EA] Climbs 6.1% After In-Line Results and Guidance Boost $ea

6. VRX:Valeant Pharmaceuticals Intl Inc Is What’s Wrong With America $VRX #healthcare…

7. YELP:Yelp beats by $0.04, beats on revenue #premarket $YELP

8. GILD:$GILD was Great Once but is Now Awful and Depressing Sad…

9. TWX:Time Warner Reports Q3 Adj. EPS $1.83 vs $1.37 Est., Sales $7.2B vs $7B Est. $TWX

10. TRIL:$TRIL Trillium Therapeutics Advances TTI-621 Into Phase 1b Cohort Expansion Enrollment #CD47

11. BABA:$BABA Alibaba Q3 16 Earnings Results: -Adj EPS: $0.79 -Revenue: $5.1B

Trending News Headlines

1. Gilead was great once but is now awful and depressing

I want the old Gilead back! The present Gilead, with a stock down 27% for the year, trading at levels not seen since April 2014, is too sad to bear.

2. Andy Biotech on Twitter

“$CEMP — Long list of safety/pharmacokinetic/efficacy issues that FDA identified”

3. Andy Biotech on Twitter

“$CEMP — FDA: “We conclude that these findings comprise a genuine liver injury signal. “”

4. Briefing Information for the November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance

5. 2016 Meeting Materials, Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee)

6. Palatin female libido-boosting shot fails crucial sex frequency test

Palatin appears be to playing a game of bait and switch with the design of its phase III studies.

7. Alibaba Jumps On Q3 Earnings Beat; Cloud Loss Narrowed

Alibaba Group (BABA) jumped 3.6% in pre-market after reporting better-than-expected third-quarter earnings. Revenue at Alibaba grew 55% from a year ago to 34.29 billion yuan, broadly in line with the 54% growth predicted by the street. But earnings per share came in at 5.26 yuan ($0.79), well above street estimate of 4.69 yuan, or $0.69. […]

8. Andy Biotech on Twitter

“$CEMP — As expected, liver tox is the key focus of solithromycin safety issues”

9. U.S. Steel Cuts Annual View, Posts Third-Quarter Profit

U.S. Steel Corp. lowered its full-year guidance as it continues to recover from unplanned outages in the third quarter and invest in additional maintenance spending. The company posted a third-quarter profit.

10. Gilead Quarterly Profit Misses on Low Hepatitis C Drug Sales

Gilead Sciences Inc. posted third-quarter profit that missed analysts’ estimates amid steadily declining sales of its hepatitis C drugs, though it isn’t rushing to fill its pipeline with deals.

11. zach on Twitter

“yikes $CEMP”

12. Yelp shares jump after company reports surprise profit

13. Private companies created fewer jobs than expected in October as pace of growth slows

ADP also revised job creation numbers for other months as part of a new measuring model.

14. Chipmaker Broadcom to buy network gear maker Brocade for $5.5 billion

Chipmaker Broadcom Ltd (AVGO.O) said on Wednesday it would buy network gear maker Brocade Communications Systems Inc (BRCD.O) for $5.5 billion in cash, to expand its fiber channel and data storage businesses.

15. Allergan expands buyback to $15 billion, sets first quarterly dividend

Allergan Plc (AGN.N) on Wednesday expanded its share buyback program by $5 billion to $15 billion and set its first-ever quarterly dividend, cushioning the impact of lower-than-expected quarterly revenue and lifting its shares.

Technology News

1. Look what quietly passed on the night everyone was out partying for halloween

2. Best summary of Apple’s conundrum with the Mac: “We demand Apple innovate, but we insist they don’t change anything”

3. Some news: we are shutting down the Talkshow app and website on December 1. Thank you to all of our Talkshow hosts.

4. Windows flaw being exploited by Russian group behind DNC hacks, patch not coming until Election Day

5. The DMCA is crap, but the exemption for security researchers is big win:

6. Some Apple SSD updates are now cheaper! Instead of ludicrously overpriced they are just insanely overpriced.

7. possible future e-commerce stuff for Instagram: – comparison shopping – saving products you like – product search

8. Instagram adopts serendipitous commerce. Amazon & Google if you know what you want, Insta & Pinterest if you don’t

9. Amazon charges non-Prime members more at physical bookstores, hinting at new retail strategy

10. Instagram commerce makes a lot more sense than Facebook commerce, but no native purchase flow is too much friction

PRE-MARKET | November 01, 2016 | $BP, $CMG, $CVX, $GILD, $X, $CMI, $TAP, $HLF, $COH, $PFE, $ICE #traders, #options

by Alpha | Nov 1, 2016 | Pre-Market

PRE-MARKET MOVERS

1. FLXN:

$FLXN Flexion Therapeutics Reports Primary Endpoint Met in Zilretta™ – GlobeNewswire

2. DRRX:

$DRRX DURECT Corp Tops Q3 EPS by 1c; Issues Update on DUR-928 Program – Street Insider

3. RYAM:

$RYAM Rayonier Advanced Materials Tops Q3 EPS by 20c; Raises Outlook – Street Insider

4. CGNX:

$CGNX Cognex Corp Reports Q3 EPS of $0.63; Issues Solid Q4 Revenue Outlook – Street Insider

5. INCY:

$INCY Incyte Reports 2016 Third-Quarter Financial Results and Updates Key Clinical Programs – Biz Wire

6. AMKR:

$AMKR Amkor Technology Tops Q3 EPS by 4c; Updates FY16 Outlook – Street Insider

7. OSK:

$OSK Oshkosh Corporation Reports Fiscal 2016 Fourth Quarter and Full Year Results – Business Wire

8. ANGI:

$ANGI Angie’s List shares soar 10.5% premarket after company hires advisers to explore options – MW

9. RDS:

$RDS/A Royal Dutch Shell Beats Q3 Earnings on Higher Output – Zacks

10. IDTI:

$IDTI Integrated Device Technology Q2 earnings per share view $0.33 – Reuters

11. BBRY, F:

$BBRY BlackBerry signs deal with Ford $F to work on cars of the future – The Verge

12. VRX:

$VRX Valeant Pharma Issues Comments on Anonymous Press Reports – Street Insider

13. COH:

$COH Coach earnings meet expectations, but sales miss – MarketWatch

14. AA, ARNC:

$AA Alcoa Announces Completion of Arconic $ARNC Separation; Begins Trading at Independent Co. – SI

15. AMZN:

$AMZN Amazon claims bumper festive season sales this year, hints at more investments in India – BI

16. SNE:

$SNE Sony bullish on sensors after quake causes quarterly profit to halve – Reuters

17. TRI:

$TRI Thomson Reuters to cut 2,000 jobs, take fourth-quarter charge – Reuters

18. YUM, YUMC: $YUM Yum! Brands Spins Off China Unit In New York Amid Losses In Market Share $YUMC – Forbes

19. BMRN: $BMRN Biomarin Pharmaceutical CEO Jean Jacques Bienaime Sold $9.8 million of Shares – Yahoo

20. ATO, CNP: $ATO CenterPoint Energy $CNP to acquire retail energy services business from subsidiary of Atmos Energy

21. MPWR: $MPWR Monolithic Power Systems announces results for Q3 – Reuters

22. P: $P Pandora profit up 40%; plans to open more stores – MarketWatch

23. ICE: $ICE Intercontinental Exchange Posts Higher Earnings, But Trading Fees Lower – WSJ

24. K: $K Kellogg profit jumps 42% as margins improve – MarketWatch

25. APC: $APC Anadarko Narrows Loss But Misses Quarterly Revenue, Sales Marks – WSJ

26. TAP:

$TAP Molson Coors Beats Q3 Earnings; Lags on Sales – Zacks

27. PFE:

$PFE Pfizer Cuts Outlook, Ends Development of Cholesterol Drug – WSJ

28. BP:

$BP BP Posts Sharp Rise in Profit as Cost Cuts Offset Weak Oil Prices – WSJ

29. BABA:

$BABA ‘High-up’ Alibaba staffer helping SEC probe into tech giant – NYPost

30. SHPG:

$SHPG Shire plc Misses Q3 EPS by 4c – Street Insider

31. TEX:

$TEX Tough quarter for Terex Cranes – vertikal

32. RAIL:

$RAIL FreightCar America Misses Q3 EPS by 12c – Street Insider

33. LB:

$LB L Brands reports sales slow, guides profit down – MarketWatch

34. GCI, TRNC:

$TRNC Gannett $GCI pulls offer for Tronc, publisher of Chicago Tribune – Chi Trib

35. NVCN:

$NVCN Neovasc Receives Adverse Ruling in Patent Litigation with CardiAQ; Will Seek to Stay Payment – SI

UPGRADES

1. ALLE:Imperial Capital Upgrades Allegion $ALLE to Outperform

2. CVX:$CVX upgraded to Overweight at Morgan Stanley – PT raise $130 from $113

3. NEP:Avondale Partners Upgrades NextEra Energy Partners $NEP to Market Outperform

4. XRAY:Morgan Stanley Upgrades DENTSPLY International $XRAY to Overweight

5. ZBH:Zimmer Biomet Holdings was Upgraded to a Buy Rating at Needham $ZBH

DOWNGRADES

1. BHI:$BHI downgraded to Outperform at Raymond James

2. INST:Raymond James Downgrades Instructure, Inc. $INST to Outperform

3. JNPR:Morgan Stanley downgrades Juniper Networks $JNPR to Underweight, PT $20 >> Read:

4. TMP:Keefe, Bruyette & Woods Downgrades Tompkins Financial $TMP to Underperform

5. VRTX:William Blair Downgrades Vertex $VRTX to Market Perform

EARNINGS

1. RDWR:$RDWR reports FQ3 earnings of 4c EPS and $46.86M Revs –

2. SALE:$SALE reports FQ3 earnings of 10c EPS and $64.64M Revs –

3. CRCM:$CRCM reports FQ3 earnings of 2c EPS and $40.79M Revs –

4. WCG:$WCG reports FQ3 earnings of $1.63 EPS and $3.58B Revs –

5. EVHC:$EVHC reports FQ3 earnings of 36c EPS and $1.64B Revs –

6. ETN:$ETN reports FQ3 earnings of $1.15 EPS and $4.99B Revs –

7. ETN:$ETN reports inline with the Estimize EPS Consensus and misses the Estimize Revenue Consensus by $73.12M –

8. GWR:$GWR reports FQ3 earnings of 82c EPS and $501M Revs –

9. AEP:$AEP reports FQ3 earnings of $1.30 EPS and $4.70B Revs –

10. COH:$COH reports FQ1 earnings of 45c EPS and $1.04B Revs –

11. COH:$COH reports inline with the Estimize EPS Consensus and misses the Estimize Revenue Consensus by $32.91M –

12. LYB:$LYB reports FQ3 earnings of $2.31 EPS and $7.37B Revs –

13. MOS:$MOS reports FQ3 earnings of 33c EPS and $1.95B Revs –

14. PFE:$PFE reports FQ3 earnings of 61c EPS and $13.05B Revs –

15. SHOO:$SHOO reports FQ3 earnings of 74c EPS and $408.38M Revs –

16. ADM:$ADM reports FQ3 earnings of 59c EPS and $15.83B Revs –

17. XYL:$XYL reports FQ3 earnings of 54c EPS and $897M Revs –

18. XYL:$XYL reports inline with the Estimize EPS Consensus and misses the Estimize Revenue Consensus by $18.34M –

19. IDXX:$IDXX reports FQ3 earnings of 62c EPS and $448.31M Revs –

20. IDXX:$IDXX reports inline with the Estimize EPS Consensus and misses the Estimize Revenue Consensus by $6.39M –

21. CNX:$CNX reports FQ3 earnings of -15c EPS and $745.58M Revs –

22. OXY:$OXY reports FQ3 earnings of -15c EPS and $2.65B Revs –

23. MBUU:$MBUU reports FQ1 earnings of 26c EPS and $62.02M Revs –

24. DISCA:$DISCA reports FQ3 earnings of 40c EPS and $1.56B Revs –

25. DHX:$DHX reports FQ3 earnings of 10c EPS and $56.07M Revs –

26. ANGI:$ANGI reports FQ3 earnings of -28c EPS and $79.75M Revs –

27. EMR:$EMR reports FQ4 earnings of 96c EPS and $3.93B Revs –

28. CMI:$CMI reports FQ3 earnings of $2.02 EPS and $4.19B Revs –

29. RDC:$RDC reports FQ3 earnings of 30c EPS and $379.40M Revs –

30. ALLT:$ALLT reports FQ3 earnings of -1c EPS and $21.02M Revs –

31. AME:$AME reports FQ3 earnings of 56c EPS and $945.03M Revs –

32. GK:$GK reports FQ1 earnings of 89c EPS and $241.02M Revs –

33. HRS:$HRS reports FQ1 earnings of $1.39 EPS and $1.75B Revs –

34. INCY:$INCY reports FQ3 earnings of 19c EPS and $269.47M Revs –

35. AYR:$AYR reports FQ3 earnings of 38c EPS and $194.65M Revs –

36. OSK:$OSK reports FQ4 earnings of $1.05 EPS and $1.76B Revs –

37. PES:$PES reports FQ3 earnings of -29c EPS and $68.35M Revs –

38. SAH:$SAH reports FQ3 earnings of 47c EPS and $2.56B Revs –

39. TRI:$TRI reports FQ3 earnings of 54c EPS and $2.74B Revs –

40. DIN:$DIN reports FQ3 earnings of $1.46 EPS and $156.02M Revs –

41. EIGI:$EIGI reports FQ3 earnings of -24c EPS and $291.19M Revs –

42. FSS:$FSS reports FQ3 earnings of 17c EPS and $186.70M Revs –

43. HZO:$HZO reports FQ4 earnings of 18c EPS and $227.36M Revs –

44. K:$K reports FQ3 earnings of 96c EPS and $3.25B Revs –

45. NSP:$NSP reports FQ3 earnings of 78c EPS and $702.54M Revs –

46. MSM:$MSM reports FQ4 earnings of $1.02 EPS and $745.07M Revs –

47. TWIN:$TWIN reports FQ1 earnings of -24c EPS and $35.84M Revs –

48. NI:$NI reports FQ3 earnings of 6c EPS and $853.90M Revs –

49. SHPG:$SHPG reports FQ3 earnings of $3.17 EPS and $3.45B Revs –

50. SPR:$SPR reports FQ3 earnings of $1.16 EPS and $1.71B Revs –

51. ICE:$ICE reports FQ3 earnings of $3.21 EPS and $1.08B Revs –

52. CIE:$CIE reports FQ3 earnings of -18c EPS and $4.23M Revs –

53. ECL:$ECL reports FQ3 earnings of $1.28 EPS and $3.39B Revs –

54. FIS:$FIS reports FQ3 earnings of $1 EPS and $2.35B Revs –

55. NLNK:$NLNK reports FQ3 earnings of -54c EPS and $15.35M Revs –

Trending Social Alerts

1. PFE:$PFE discontinues development of its PCSK9 inhibitor.

2. GCI:Gannett to pass on Tronc, shares spike #premarket $GCI

3. INCY:$INCY Jakafi $224M sales and a guidance increase.

4. BHI:$BHI downgraded to Outperform at Raymond James

5. BABA:surprised Ackman isn’t long $BABA, has accounting irregularities, whistle-blowers and SEC investigations

6. COH:Coach Q1 EPS $0.45 vs $0.45 Est, Revenue $1.04B vs $1.07B Est. $COH

7. TRNC:Gannett terminates discussions to acquire tronc $GCI $TRNC: Full Story

8. SHPG:$SHPG terminates SHP610 after Ph2b study did not meet primary endpoint of slowing cognitive decline in pts with early stage #Sanfilippo A.

Trending News Headlines

1. ‘High-up’ Alibaba staffer helping SEC probe into tech giant

A federal probe of Alibaba’s books is far from dead — and it’s getting help from at least one insider. The Securities and Exchange Commission is working with one or more whistleblowers as it invest…

2. Pfizer Discontinues Global Development of Bococizumab, Its Investigational PCSK9 Inhibitor | Pfizer: One of the world’s premier biopharmaceutical companies

Pfizer Inc. announced today the discontinuation of the global clinical development program for bococizumab, its investigational Proprotein Convertase Subtilisin Kexin type 9 inhibitor (PCSK9i). The totality of clinical information now available for bococizumab, taken together with the evolving treatment and market landscape for lipid-lowering agents, indicates that bococizumab is not likely to provide value to patients, physicians, or shareholders. As a result, Pfizer has decided to discontinue the development program, including the two ongoing cardiovascular outcome studies.

3. Pfizer Cuts Outlook, Ends Development of Cholesterol Drug

Pfizer Inc. on Tuesday lowered its earnings outlook for the year and said it was ending the development of a drug in the massive cholesterol-treatment sector.

4. Pfizer profit just misses; company scraps cholesterol drug

Pfizer Inc (PFE.N), the largest U.S. drugmaker, reported a quarterly adjusted profit that just missed analysts’ estimates, and the company shaved 4 cents off its 2016 earnings forecast after scrapping development of a cholesterol-lowering treatment.

5. Gannett ends talks to buy Tronc

This story is developing. Please check back for further updates.

6. Gannett Abandons Its Attempt to Buy Tronc

Newspaper company Gannett has dropped its bid to buy Chicago Tribune publisher Tronc, ending a monthslong pursuit of its rival.

7. Tronc is crashing after Gannett terminates buyout talks

The owner of the USA Today is not buying the owner of the Chicago Tribune and the stocks are crashing.

8. Gannett Abandons Effort to Buy Newspaper Publisher Tronc